News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
613,934 Results
Type
Article (36512)
Company Profile (121)
Press Release (577301)
Section
Business (172161)
Career Advice (2745)
Deals (32293)
Drug Delivery (85)
Drug Development (72321)
Employer Resources (156)
FDA (15513)
Job Trends (14495)
News (299222)
Policy (28813)
Tag
Academia (2646)
Alliances (43040)
Alzheimer's disease (1343)
Approvals (15503)
Artificial intelligence (196)
Bankruptcy (284)
Best Places to Work (12093)
Breast cancer (222)
Cancer (1673)
Cardiovascular disease (125)
Career advice (2271)
CAR-T (122)
Cell therapy (363)
Clinical research (58461)
Collaboration (664)
Compensation (371)
COVID-19 (2437)
C-suite (167)
Data (1655)
Diabetes (204)
Diagnostics (6520)
Earnings (67029)
Employer resources (137)
Events (100745)
Executive appointments (588)
FDA (16425)
Funding (599)
Gene therapy (250)
GLP-1 (545)
Government (3984)
Healthcare (19778)
Infectious disease (2545)
Inflammatory bowel disease (124)
Interviews (540)
IPO (16117)
Job creations (2861)
Job search strategy (1889)
Layoffs (396)
Legal (6339)
Lung cancer (238)
Manufacturing (223)
Medical device (13883)
Medtech (13888)
Mergers & acquisitions (16645)
Metabolic disorders (475)
Neuroscience (1749)
NextGen: Class of 2025 (6706)
Non-profit (4822)
Northern California (2128)
Obesity (240)
Opinion (214)
Parkinson's disease (120)
Patents (159)
People (51129)
Phase I (18208)
Phase II (25968)
Phase III (19349)
Pipeline (697)
Postmarket research (2016)
Preclinical (7394)
Radiopharmaceuticals (250)
Rare diseases (328)
Real estate (4881)
Regulatory (20135)
Research institute (2430)
Resumes & cover letters (449)
Southern California (1834)
Startups (3026)
United States (18789)
Vaccines (558)
Weight loss (144)
Date
Today (17)
Last 7 days (608)
Last 30 days (2630)
Last 365 days (35127)
2025 (4564)
2024 (35959)
2023 (41286)
2022 (52115)
2021 (57040)
2020 (55564)
2019 (48731)
2018 (36629)
2017 (32101)
2016 (30368)
2015 (35472)
2014 (24629)
2013 (19205)
2012 (20726)
2011 (21532)
2010 (18623)
Location
Africa (755)
Arizona (138)
Asia (35811)
Australia (6390)
California (4811)
Canada (1721)
China (384)
Colorado (220)
Connecticut (241)
Europe (82809)
Florida (702)
Georgia (175)
Illinois (463)
Indiana (264)
Maryland (737)
Massachusetts (3730)
Michigan (218)
Minnesota (339)
New Jersey (1363)
New York (1370)
North Carolina (892)
Northern California (2128)
Ohio (178)
Pennsylvania (1108)
South America (1078)
Southern California (1834)
Texas (706)
Utah (152)
Washington State (477)
613,934 Results for "oncopeptides ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa
Oncopeptides AB (STO: ONCO), a biotech company focused on difficult-to-treat cancers, and Vector Pharma FZCO (“Vector”) today announced a collaboration to commercialize Oncopeptides’ flagship drug Pepaxti (melphalan flufenamide) in the Middle East and North Africa (“MENA”) countries of Saudi Arabia, Qatar, UAE, Bahrain, Kuwait, Oman, Algeria, Tunisia, Morocco, Libya, Lebanon, and Iraq.
March 27, 2024
·
4 min read
Press Releases
AB Science will participate in the Biomed Forum investors conference
January 22, 2025
·
2 min read
Press Releases
AB Science today provides an update on its masitinib platform
January 30, 2025
·
4 min read
Press Releases
Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome from Asarina Pharma AB
February 6, 2025
·
7 min read
Press Releases
Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent
February 21, 2025
·
11 min read
Press Releases
Breckenridge announces final FDA approval for Everolimus tablets for oral suspension, AB-rated to AFINITOR DISPERZ®
January 30, 2025
·
3 min read
Deals
Bulletin from an Extra Ordinary General meeting in Oncopeptides AB (publ)
An Extraordinary General Meeting in Oncopeptides AB (publ) (ONCO) was held on Friday, 23 September 2022 . At the Extraordinary General Meeting, the following principal resolution was passed.
September 23, 2022
·
3 min read
Vitrolife AB (publ) completes the acquisition of eFertility
Vitrolife AB has completed the acquisition of eFertility as previously communicated in the press release on 2 May 2024.
May 22, 2024
·
1 min read
Press Releases
AB Science provides a summary of the webcast held on December 16, 2024
December 17, 2024
·
7 min read
Press Releases
Pharming announces public cash offer to the shareholders of Abliva AB
December 16, 2024
·
10 min read
1 of 61,394
Next
